Schabel Jr, 1985 - Google Patents
Rationale for perioperative anticancer treatmentSchabel Jr, 1985
- Document ID
- 681662000833631052
- Author
- Schabel Jr F
- Publication year
- Publication venue
- Perioperative Chemotherapy: Rationale, Risk and Results
External Links
Snippet
I will limit my discussion essentially to chemotherapy as an adjuvant to surgery, since my experience is in this field, but I recognize that radiation therapy could be substituted for surgery in many cases and also that there are clinical examples of all three modalities being …
- 230000001093 anti-cancer 0 title description 6
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schabel Jr | Rationale for adjuvant chemotherapy | |
| Nigro et al. | Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal | |
| Salsbury et al. | Inhibition of metastatic spread by ICRF 159: selective deletion of a malignant characteristic | |
| Laster Jr et al. | Success and failure in the treatment of solid tumors. II. Kinetic parameters and “cell cure” of moderately advanced carcinoma 755 | |
| Steeves et al. | Cosmesis and local control after irradiation in women treated conservatively for breast cancer | |
| Påhlman | Perioperative radiotherapy in rectal cancer | |
| Schabel Jr | Concepts for treatment of micrometastases developed in murine systems | |
| Schabel Jr | Rationale for perioperative anticancer treatment | |
| Cummings | Current management of epidermoid carcinoma of the anal canal | |
| Papaioannou | Preoperative chemotherapy for operable solid tumours | |
| CN111617235A (en) | Application of IL-12 in postoperative antitumor aspect | |
| Straus et al. | Effects of priming dose schedules in methotrexate treatment of mouse leukemia L1210 | |
| Carter | Immunotherapy of Cancer in Man: Modification of the body's own immune responses shows increasing promise as a method of cancer treatment | |
| RU2285548C2 (en) | Method for treating oncologic patients | |
| Lee et al. | Adjuvant postoperative chemotherapy with 5‐fluorouracil and methotrexate: Effect of schedule of administration on metastasis of 13762 mammary adenocarcinoma | |
| Cohen et al. | Effect of treatment with the MER tubercle bacilli fraction on the survival of mice carrying mammary tumour isografts: injection of MER at the tumour site or at a distal location | |
| Helson et al. | Sequential hemi-body irradiation (HBI) in treatment of advanced neuroblastoma: A pilot study | |
| Kemeny et al. | The effects on liver metastases of circadian patterned continuous hepatic artery infusion of FUDR | |
| RU2242998C1 (en) | Method for treating pulmonary cancer | |
| Cornbleet et al. | High-dose alkylating agent therapy: a review of clinical experiences | |
| Wassif | A pilot study for the evaluation of a new regime of combined therapy for the radical treatment of marginally operable rectal (or colo-rectal) cancer | |
| Mahadevan et al. | Goserelin-Induced Chemical Burn: A Case Report and Review of the Literature | |
| Ruipeng et al. | Current Status of the Appli-cation of Immune Checkpoint Inhibitors in Liver Trans-plantation for Hepatocellular Carcinoma | |
| Shingleton et al. | Adjuvant therapy of colorectal cancer | |
| Papaioannou | Preoperative chemotherapy: advantages and clinical application in stage III breast cancer |